Volume 73, No.2: 2021 Siriraj Medical Journal
https://he02.tci-thaijo.org/index.php/sirirajmedj/index
126
Thoongsuwan et al.
demarcated hypoautofluorescence surrounded by
hyperautouorescence, which we refer to as the ring
pattern in the current study. is nding was associated
with the polypoidal lesions seen on ICGA images. is
characteristic was observed in most eyes with PCV and
not in typical n-AMD. ose authors proposed that
the anterior protrusion of polyp lesions may induce
RPE damage.
21
However, in the current study, a ring
pattern also was seen in 18% of the fellow eyes of those
with n-AMD. erefore, this nding in FAF may not be
specic to PCV. Any pathology that involves the RPE
and causes RPE damage can demonstrate a ring pattern
as well, while a patch pattern, represented by hypo/
hyperautouorescence, is a nonspecic FAF nding that
may represent changes in RPE function in early-stage
diseases of the RPE cells and adjacent structures.
ICGA is an invasive investigation. Because of its
longer operating wavelength, ICG can uorescence through
the RPE better than uorescein dye. ICGA is useful for
detecting abnormal choroidal vasculature. e specic
characteristics of ICGA in PCV were reported and used
as diagnostic criteria.
7
However, a non-specic nding
in ICGA, such as PHS, has been described previously in
choroidal vasculopathy disorders. ose punctate spots
were believed to be in the inner choroid and possibly
the RPE layer and were found to be associated with
the hyperpermeability of the choroidal vessels causing
dye leakage in the late phase.
22,23
Park and colleagues
26
reported a higher incidence of PHS in PCV than n-AMD
in aected and contralateral eyes. ose authors suggested
that PCV may arise from choroidopathy and be distinct
from typical n-AMD.
24
In the current study, PHS was
detected in the fellow eyes of those with PCV and n-AMD
and the dierence did not reach signicance (66% in
PCV vs. 53% in n-AMD). Because the punctate spots
can be present in either the inner choroid or RPE, this
nonspecic nding may be associated with both PCV
and AMD. erefore, PHS may not be a nding specic
to PCV, in that it can be detected in AMD as well.
In the current study, compared to FAF and SD-
OCT, ICGA detected the most abnormalities in the fellow
eyes of those with PCV. About two-thirds of the fellow
eyes of those with PCV had abnormalities on ICGA
images compared with only one-third of patients with
abnormalities on FAF or SD-OCT images. is result may
suggest that patients who have normal ndings on FAF
or SD-OCT still have a risk of developing PCV in their
fellow eyes and those eyes should be monitored regularly.
Although ICGA seems to be the best investigation for
detecting choroidal pathologies, especially in early or
even preclinical disease stages, ICGA is not likely to be
performed during routine screenings because it is invasive
and complex. FAF and SD-OCT are noninvasive and
reproducible investigations, so they are more likely to
be used for screening PCV in asymptomatic eyes, even
though their abilities to detect abnormalities are lower
than that of ICGA.
The current study had several limitations. The
retrospective cross-sectional design may cause a systematic
bias toward population selection. e small sample size
and lack of follow-up also were drawbacks. Finally, the
evaluation of all images was lacking in quantitative
analysis results in subjective information.
In conclusion, most asymptomatic fellow eyes
of those with PCV and n-AMD, which are the better
eyes of patients, showed abnormalities in all current
investigations and may represent the eyes at risk. Patients
and physicians should be more concerned about the
status of these eyes. e correlation between abnormal
ndings in each imaging modality may contribute to
important information that can predict possible disease
progression. Additional longitudinal long-term studies
may facilitate a better understanding of the pathogeneses
and course of these diseases.
REFERENCES
1. van der Scha TL, Mooy CM, de Bruijn WC, Oron FG, Mulder
PG, de Jong PT. Histologic features of the early stages of age-
related macular degeneration. A statistical analysis. Ophthalmology
1992;99:278-86.
2. Green WR, Enger C. Age-related macular degeneration
histopathologic studies. The 1992 Lorenz E. Zimmerman
Lecture. Ophthalmology 1993;100:1519-35.
3. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T,
Nickerson RS, et al. e Framingham Eye Study. I. Outline
and major prevalence ndings. Am J Epidemiol 1977;106:17-
32.
4. Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY,
Freund KB. Pachychoroid disease. Eye (Lond) 2019;33:14-33.
5. Ferris FL, Davis MD, Clemons TE, Lee LY, Chew EY, Lindblad AS,
et al. A simplified severity scale for age-related macular
degeneration: AREDS Report No. 18. Arch Ophthalmol 2005;
123:1570-4.
6. Chew EY, Clemons TE, Agron E, Sperduto RD, Sangiovanni
JP, Davis MD, et al. Ten-year follow-up of age-related macular
degeneration in the age-related eye disease study: AREDS
report no. 36. JAMA Ophthalmol 2014;132:272-7.
7. Koh A, Won Ki Lee,Lee-Jen Chen,Shih-Jen Chen,Yehia
Hashad,Hakyoung Kim, et al. EVEREST study: ecacy and
safety of verteporn photodynamic therapy in combination with
ranibizumab or alone versus ranibizumab monotherapy in
patients with symptomatic macular polypoidal choroidal
vasculopathy. Retina 2012;328:1453-64.
8. Argon laser photocoagulation for senile macular degeneration.
Results of a randomized clinical trial. Arch Ophthalmol 1982;
100:912-8.